Reported 12 months ago
As the COVID-19 pandemic intensifies, the demand for home rapid antigen tests has surged in Taiwan, with 4 approved brands listed by the Taiwan FDA including 'FeiQueRV2', 'Genomax', 'Formosa Biomedical', and 'Abbott'. With concerns over a potential shortage, the FDA assured an adequate domestic supply. Amid the Omicron surge, experts anticipate a peak in mid-July. Major variants like JN.1, KP.2, and KP.3 remain detectable by current testing methods. Additionally, there are reports of shortages in children's antibiotic syrup 'Curam', yet alternative products are available in Taiwan.
Source: YAHOO